spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Alta Partners 

 HSMN NewsFeed - 19 Apr 2017
USGI Medical Appoints Carlos Babini as President and Chief Executive Officer
Devices Gastroenterology Personnel
 HSMN NewsFeed - 16 Mar 2017
eGenesis Announces $38 Million Series A Financing, Led by Biomatics Capital and ARCH Venture Partners, to Solve Shortage of Organs for Donation
Regenerative Medicine Venture Capital
 HSMN NewsFeed - 19 Jan 2016
Allakos Successfully Completes Dosing in Phase 1 Clinical Trial of AK001 and Announces Expansion of its Executive Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Feb 2015
aTyr Pharma Receives EMA Orphan Drug Designation for Resolaris(TM) in FSHD
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 22 Oct 2014
aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Jul 2014
Virobay Completes $8 Million Series B Preferred Stock Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 28 Mar 2014
aTyr Pharma Appoints David M. Weiner, M.D., as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Mar 2014
Lumena Pharmaceuticals Raises $45 Million in Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 11 Feb 2014
Lithera Announces Final Closing of $35.6 Million Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 5 Feb 2014
aTyr Pharma Appoints Frederic Chereau as President and Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Dec 2013
AcelRx Pharmaceuticals Adds New Board Member
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Nov 2013
Kiadis Pharma Provides Positive Update on its Phase II Clinical Program with Blood Cancer Treatment ATIR(TM)
Biopharmaceuticals
 HSMN NewsFeed - 30 Oct 2013
Immune Design Raises Up to $49 Million Series C Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 26 Sep 2013
Lumena Pharmaceuticals Receives Orphan Drug Designation from US Food & Drug Administration for LUM001 in Four Rare Liver Diseases
Biopharmaceuticals FDA
 HSMN NewsFeed - 4 Dec 2012
Zafgen Secures $21 Million in Series D Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 19 Nov 2012
AGTC Secures $37.5M Series B Funding
Biopharmaceuticals Ophthalmology Venture Capital
 HSMN NewsFeed - 5 Nov 2012
Pathwork Diagnostics Inc. Appoints Lee McCracken as CEO
Diagnostics Oncology Personnel
 HSMN NewsFeed - 8 May 2012
Sutro Closes $16.5 Million Second Tranche of Series C Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 7 May 2012
Kerberos to Sell FDA Cleared Rinspiration Technology
Devices Interventional Cardiology
 HSMN NewsFeed - 2 Dec 2011
Pfizer Completes Acquisition of Excaliard
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 18 Jul 2011
SARcode Bioscience Completes $44 Million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 7 Mar 2011
Aerie Pharmaceuticals Completes $30 Million Series B Financing to Fund Further Development of Innovative Glaucoma Product Portfolio
Biopharmaceuticals Ophthalmology Venture Capital
 HSMN NewsFeed - 1 Feb 2011
VertiFlex(R), Inc. Announces Financing and New Investment Partner
Devices Orthopaedic Neurosurgery Venture Capital
 HSMN NewsFeed - 4 Jan 2011
PneumRx, Inc. Raises $33 Million in Capital
Devices Venture Capital
 HSMN NewsFeed - 17 Nov 2010
Sutro Biopharma Secures $36.5 Million in Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 11 Nov 2010
Ceregene Raises $11.5 Million in Series D Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 26 Oct 2010
aTyr Pharma Secures $23M Financing From Top Tier Venture Investor
Biopharmaceuticals Venture Captial
 HSMN NewsFeed - 21 Oct 2010
Cerenis Therapeutics raises additional €10 million to close €50 million Series C financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 6 Oct 2010
Pathwork Diagnostics Completes $30M Series C Round
Diagnostics Personalized Medicine Venture Capital
 HSMN NewsFeed - 1 Sep 2010
Pfizer to Acquire FoldRx Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 23 Aug 2010
Taligen Closes $10 Million Series B Financing Tranche
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 26 Jul 2010
Immune Design Corp. Raises $32 Million in Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 26 Jul 2010
Cerenis Therapeutics raises 40 million in series C financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 21 Jul 2010
Chimerix Appoints Two New Vice Presidents to Clinical Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Jul 2010
Trevena Secures $35 Million in Series B Funding to Progress Portfolio of GPCR Biased Ligands and to Complete Phase 2 Study of TRV120027 for Acute Heart Failure
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 30 Jun 2010
Calistoga Pharmaceuticals Raises $40 Million in Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 14 Jun 2010
aTyr Pharma Appoints Catharine E. Johnson As Senior Vice President of Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 May 2010
Dr. John Mendlein Joins aTyr Pharma as Executive Chairman
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 May 2010
Chimerix Appoints Thomas Pitler, Ph.D., Vice President, Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Apr 2010
Achaogen Completes $56 Million Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 4 Feb 2010
Chimerix Names Wendy Painter, M.D., M.P.H., as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Dec 2009
Silence Therapeutics to Merge with Intradigm Corp to Create Leading RNAi Therapeutics Company
Biopharmaceuticals Mergers & Acquisitions Personnel
 HSMN NewsFeed - 5 Nov 2009
Metabolex Closes $8.6 Million Financing Round
Biopharmaceuticals Endocrinology Venture Capital
 HSMN NewsFeed - 11 Aug 2009
Chimerix Raises $16.1 Million in Series E Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 5 Aug 2009
Ceregene Receives Additional Grant From Michael J. Fox Foundation to Expand Long-Term Testing of CERE-120 Patients
Biopharmaceuticals Neurology
 HSMN NewsFeed - 28 Jul 2009
aTyr Pharma Raises an Additional $12 Million
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 21 May 2009
Avid Radiopharmaceuticals Closes $34.5 Million Series D Financing
Biopharmaceuticals Radiology Neurology Venture Capital
 HSMN NewsFeed - 5 May 2009
Calistoga Pharmaceuticals Raises $30 Million in Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 7 Apr 2009
Aerovance Secures $38 Million in Equity Financing
Devices Drug Delivery Venture Capital
 HSMN NewsFeed - 2 Oct 2008
Intradigm Raises $18.5 Million in Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 25 Sep 2008
MacroGenics Raises $25M in Series D-2 Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 22 Sep 2008
VertiFlex Strengthens its Executive Management Team
Devices Orthopaedic Neurosurgery Personnel
 HSMN NewsFeed - 23 Jun 2008
Immune Design Announces $18 Million Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 21 May 2008
Daiichi Sankyo Co., Ltd. Announces Acquisition of Biotech Firm U3 Pharma AG
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 1 May 2008
Esperion Therapeutics Completes $22.75 M Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 23 Apr 2008
Ceregene Announces Two Key Additions to Leadership Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Mar 2008
Corcept Therapeutics Announces $25.3 Million Private Equity Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 5 Mar 2008
Trevena, Inc. Announces $24 Million Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 13 Feb 2008
Calistoga Pharmaceuticals Announces Appointment of R. Lee Douglas, 22-Year Biotechnology/Pharmaceutical Industry Veteran, to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Feb 2008
Taligen Therapeutics Secures Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 31 Jan 2008
Sonexa Therapeutics, Inc., Raises $30 Million in Series A Financing to Focus on Alzheimer's Treatments
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 3 Jan 2008
Calistoga Pharmaceuticals Announces Completion of Its Series A Financing -- Investors Increased Funding by 25% to Total $26.2 Million
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 17 Dec 2007
Alta Partners Announces $25 Million Investment in Anesiva, Inc.
Biopharmaceuticals Drug Delivery Venture Capital
 HSMN NewsFeed - 10 Dec 2007
Fundamental Applied Biology, Inc. Completes $21 Million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 6 Dec 2007
Ceregene Promotes Dr. Raymond Bartus to Executive Vice President
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Nov 2007
Carbylan Announces $20 Million Series B Financing
Devices Venture Capital
 HSMN NewsFeed - 20 Aug 2007
Corcept Therapeutics Announces $10.1 Million Private Equity Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 9 Aug 2007
Nereus Pharmaceuticals Raises $45 Million in Series D-2 Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 12 Jul 2007
Agensys Raises $41 Million
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 28 Jun 2007
Paracor Medical, Inc. Announces Series D Funding
Devices Cardiology Venture Capital
 HSMN NewsFeed - 21 Jun 2007
Ceregene and Genzyme Announce Partnership for the Development and Commercialization of Cere-120 for Parkinson's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 19 Jun 2007
ATS Medical to Acquire CryoCath Technologies' Surgical Cryoablation Business
Devices Cardiology Acquisitions
 HSMN NewsFeed - 23 May 2007
Prolacta Bioscience Closes on over $12 Million in Private Funding
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 23 May 2007
Arete Therapeutics Raises $35 Million
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 7 May 2007
Portola Pharmaceuticals, Inc. Announces Completion of $70 Million Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 2 May 2007
Ceregene Presents Interim Phase 1 Clinical Data of CERE-110 for the Treatment of Alzheimer's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 19 Apr 2007
Metabolex Raises $32 Million to Accelerate Clinical Development Programs for Its Pipeline of Drug Candidates in Metabolic Disease
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 13 Apr 2007
TransMedics, Inc., Closes $25.5 Million in Series D Funding
Devices Venture Capital
 HSMN NewsFeed - 13 Apr 2007
Ceregene Enrolling Patients for Phase 2 Clinical Trial of Parkinson's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 31 Mar 2007
Corcept Therapeutics Announces $9 Million Private Equity Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 27 Mar 2007
Sanarus Medical, Inc. Appoints Randy D. Lindholm to Board of Directors
Devices Personnel
 HSMN NewsFeed - 22 Mar 2007
Sanarus Medical, Inc. Appoints John F. Howe as President and Chief Executive Officer
Devices Personnel
 HSMN NewsFeed - 15 Mar 2007
Sanarus Medical Secures $15 Million Round of Financing
Devices Surgery Venture Capital
 HSMN NewsFeed - 8 Mar 2007
Phenomix Completes $55 Million Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 5 Mar 2007
Calistoga Pharmaceuticals, A Newly Formed Drug Development Company, Announces Its Formation and Completion of a $21 Million Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 20 Feb 2007
Steven T. Sobieski Joins Insulet Corporation's Board of Directors
Devices Drug Delivery Personnel
 HSMN NewsFeed - 7 Feb 2007
Proacta Inc Completes $35M Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 1 Feb 2007
AstraZeneca Acquires Arrow Therapeutics To Broaden Anti-Infective Capabilities
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 29 Jan 2007
Icagen Announces $22 Million Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 28 Nov 2006
Cara Therapeutics Secures $19 Million in Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 21 Nov 2006
Intradigm Announces Significant Enhancements of the Company Capabilities, a New Series A Financing and Important Addition to Senior Management Team
Biopharmaceuticals Personnel Venture Capital
 HSMN NewsFeed - 13 Nov 2006
Cerenis Therapeutics Closes EUR 42.1 Million Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 4 Oct 2006
TorreyPines Therapeutics Completes Merger With Axonyx
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 1 Jun 2006
Ablynx Strengthens Management Team - Eva-Lotta Allan Joins as Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 May 2006
FoldRx Pharmaceuticals Closes $43 Million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 10 May 2006
Astex Announces New Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 May 2006
Aerovance Secures $60 Million in Financing
Biopharmaceuticals Venture Capital
Return to NewsFeed  

 Additional items found! 39

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 39 additional stories matching:
Alta Partners
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.